{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "03", "@year": "2024", "@timestamp": "2024-11-03T11:58:20.000020-05:00", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425668"}, "@dptid": "104425668"}, "author": [{"ce:given-name": "Nithidol", "preferred-name": {"ce:given-name": "Nithidol", "ce:initials": "N.", "ce:surname": "Sakunrangsit", "ce:indexed-name": "Sakunrangsit N."}, "@seq": "1", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Sakunrangsit", "@auid": "57190619358", "ce:indexed-name": "Sakunrangsit N."}, {"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Ketchart", "@auid": "37029887800", "ce:indexed-name": "Ketchart W."}]}, {"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Systems Biology Center"}, {"$": "Research Affairs"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "115138551"}, "@dptid": "115138551"}, "author": [{"ce:given-name": "Nuttiya", "preferred-name": {"ce:given-name": "Nuttiya", "ce:initials": "N.", "ce:surname": "Kalpongnukul", "ce:indexed-name": "Kalpongnukul N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Kalpongnukul", "@auid": "56784217400", "ce:indexed-name": "Kalpongnukul N."}, {"ce:given-name": "Trairak", "preferred-name": {"ce:given-name": "Trairak", "ce:initials": "T.", "ce:surname": "Pisitkun", "ce:indexed-name": "Pisitkun T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Pisitkun", "@auid": "6507728111", "ce:indexed-name": "Pisitkun T."}]}], "citation-title": "Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation", "abstracts": "Copyright \u00a9 2016 John Wiley & Sons, Ltd.Tamoxifen is widely used as the first line drug for estrogen receptor-positive subtype which is expressed in 70% of overall breast cancer patients. However, approximately 50% of these patients develop acquired resistance after 5 years of treatment, which is characterized by tumor recurrence and metastasis. The epithelial mesenchymal transition (EMT) is an important process in breast cancer invasion. Fundamentally, targeting the EMT represents a crucial therapeutic strategy for preventing or treating breast cancer metastasis. Plumbagin (PLB) is a natural naphthoquinone with significant anticancer effects against several types of tumor cells including breast cancer. In this study, we investigated the effect of PLB on human endocrine-resistant breast cancer cell growth, invasion and the possible mechanisms underlying such actions. PLB exhibited potent cytotoxic activity at a micromolar concentration against endocrine-resistant breast cancer cells. Interestingly, a fixed low concentration of PLB and tamoxifen combination resulted in an increase in growth inhibition in endocrine-resistant cells. In addition, PLB also significantly suppressed mesenchymal biomarker expressions that govern the EMT process, resulting in attenuated metastatic capabilities. In conclusion, PLB should be developed as a pharmacological agent for the use as a single treatment or in combination for endocrine-resistant breast cancer. Copyright \u00a9 2016 John Wiley & Sons, Ltd.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "cytotoxicity", "@xml:lang": "eng"}, {"$": "EMT", "@xml:lang": "eng"}, {"$": "endocrine-resistant breast cancer", "@xml:lang": "eng"}, {"$": "metastasis", "@xml:lang": "eng"}, {"$": "plumbagin", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1573", "@type": "email"}}, "translated-sourcetitle": {"$": "Phytotherapy Research", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "30", "@issue": "12"}, "pagerange": {"@first": "1968", "@last": "1977"}}, "@type": "j", "sourcetitle": "Phytotherapy Research", "publicationdate": {"month": "12", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 December 2016"}, "day": "01"}, "codencode": "PHYRE", "sourcetitle-abbrev": "Phytother. Res.", "@country": "gbr", "issn": [{"$": "10991573", "@type": "electronic"}, {"$": "0951418X", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"affiliation": {"address-part": "Southern Gate", "postal-code": "PO19 8SQ", "@country": "gbr", "city": "Chichester, West Sussex"}, "publishername": "John Wiley and Sons Ltd"}, "@srcid": "16573"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "87.2.5", "classification-description": "CANCER RESEARCH; TUMOUR BIOLOGY; Invasion and Metastasis"}, {"classification-code": "87.4.1", "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy"}, {"classification-code": "87.5.11", "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Breast"}, {"classification-code": "89.5.2.6", "classification-description": "CELL AND DEVELOPMENTAL BIOLOGY; CELL TYPES AND BIOLOGY; Tumour Cell Biology; Invasion and metastasis"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": "3004"}, {"@type": "SUBJABBR", "classification": "PHAR"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "129453-61-8", "chemical-name": "fulvestrant"}, {"cas-registry-number": "481-42-5", "chemical-name": "plumbagin"}, {"cas-registry-number": "10540-29-1", "chemical-name": "tamoxifen"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Anticoagulants"}, {"chemical-name": "Naphthoquinones"}, {"chemical-name": "plumbagin"}, {"chemical-name": "Tamoxifen"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "EMBIO"}, {"$": "MEDL"}, {"$": "REAXYS"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "28", "@year": "2016", "@timestamp": "BST 09:26:45", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "611691426", "@idtype": "PUI"}, {"$": "2016285241", "@idtype": "CABS"}, {"$": "653916611", "@idtype": "CAR-ID"}, {"$": "20160599607", "@idtype": "EMBASE"}, {"$": "2016583341", "@idtype": "EMBIO"}, {"$": "27530731", "@idtype": "MEDL"}, {"$": "2016210516", "@idtype": "REAXYS"}, {"$": "20161755387", "@idtype": "REAXYSCAR"}, {"$": "2016242556", "@idtype": "RMC"}, {"$": "84981718135", "@idtype": "SCP"}, {"$": "84981718135", "@idtype": "SGR"}, {"$": "615081110", "@idtype": "PUIsecondary"}], "ce:doi": "10.1002/ptr.5702"}}, "tail": {"bibliography": {"@refcount": "29", "reference": [{"ref-fulltext": "Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. 2008. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. J Cell Biochem 105: 1461\u20131471.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2"}, "refd-itemidlist": {"itemid": {"$": "57349119169", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "105"}, "pagerange": {"@first": "1461", "@last": "1471"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ahmad", "ce:indexed-name": "Ahmad A."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Banerjee", "ce:indexed-name": "Banerjee S."}, {"@seq": "3", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang Z."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Kong", "ce:indexed-name": "Kong D."}, {"@seq": "5", "ce:initials": "F.H.", "@_fa": "true", "ce:surname": "Sarkar", "ce:indexed-name": "Sarkar F.H."}]}, "ref-sourcetitle": "J Cell Biochem"}}, {"ref-fulltext": "Ali S, Coombes RC. 2002. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2: 101\u2013112.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Endocrine-responsive breast cancer and strategies for combating resistance"}, "refd-itemidlist": {"itemid": {"$": "0036488531", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "101", "@last": "112"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ali", "ce:indexed-name": "Ali S."}, {"@seq": "2", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Coombes", "ce:indexed-name": "Coombes R.C."}]}, "ref-sourcetitle": "Nat Rev Cancer"}}, {"ref-fulltext": "Aziz MH, Dreckschmidt NE, Verma AK. 2008. Plumbagin, a medicinal plant\u2013derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res 68: 9024\u20139032.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Plumbagin, a medicinal plant\u2013derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer"}, "refd-itemidlist": {"itemid": {"$": "55349147671", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "9024", "@last": "9032"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Aziz", "ce:indexed-name": "Aziz M.H."}, {"@seq": "2", "ce:initials": "N.E.", "@_fa": "true", "ce:surname": "Dreckschmidt", "ce:indexed-name": "Dreckschmidt N.E."}, {"@seq": "3", "ce:initials": "A.K.", "@_fa": "true", "ce:surname": "Verma", "ce:indexed-name": "Verma A.K."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Brunner N, Boysen B, Jirus S, et al. 1997. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Cancer Res 57: 3486\u20133493.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen"}, "refd-itemidlist": {"itemid": {"$": "15644377090", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "57"}, "pagerange": {"@first": "3486", "@last": "3493"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Brunner", "ce:indexed-name": "Brunner N."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Boysen", "ce:indexed-name": "Boysen B."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Jirus", "ce:indexed-name": "Jirus S."}], "et-al": null}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Brunner N, Frandsen TL, Holst-Hansen C, et al. 1993. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res 53: 3229\u20133232.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780"}, "refd-itemidlist": {"itemid": {"$": "0027279120", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "3229", "@last": "3232"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Brunner", "ce:indexed-name": "Brunner N."}, {"@seq": "2", "ce:initials": "T.L.", "@_fa": "true", "ce:surname": "Frandsen", "ce:indexed-name": "Frandsen T.L."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Holst-Hansen", "ce:indexed-name": "Holst-Hansen C."}], "et-al": null}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Butt AJ, McNeil CM, Musgrove EA, Sutherland RL. 2005. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12: 47\u201359.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E"}, "refd-itemidlist": {"itemid": {"$": "25844515780", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "47", "@last": "59"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Butt", "ce:indexed-name": "Butt A.J."}, {"@seq": "2", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "McNeil", "ce:indexed-name": "McNeil C.M."}, {"@seq": "3", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Musgrove", "ce:indexed-name": "Musgrove E.A."}, {"@seq": "4", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Sutherland", "ce:indexed-name": "Sutherland R.L."}]}, "ref-sourcetitle": "Endocr Relat Cancer"}}, {"ref-fulltext": "Chou TC. 2010. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method. Cancer Res 70: 440\u2013446.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Drug combination studies and their synergy quantification using the Chou\u2013Talalay method"}, "refd-itemidlist": {"itemid": {"$": "76549129820", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "70"}, "pagerange": {"@first": "440", "@last": "446"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.C.", "@_fa": "true", "ce:surname": "Chou", "ce:indexed-name": "Chou T.C."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Clemons M, Goss P. 2001. Estrogen and the risk of breast cancer. N Engl J Med 344: 276\u2013285.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Estrogen and the risk of breast cancer"}, "refd-itemidlist": {"itemid": {"$": "0035945656", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "344"}, "pagerange": {"@first": "276", "@last": "285"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Clemons", "ce:indexed-name": "Clemons M."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Goss", "ce:indexed-name": "Goss P."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Drake JM, Strohbehn G, Bair TB, Moreland JG, Henry MD. 2009. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol Biol Cell 20: 2207\u20132217.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells"}, "refd-itemidlist": {"itemid": {"$": "65249101685", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "2207", "@last": "2217"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Drake", "ce:indexed-name": "Drake J.M."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Strohbehn", "ce:indexed-name": "Strohbehn G."}, {"@seq": "3", "ce:initials": "T.B.", "@_fa": "true", "ce:surname": "Bair", "ce:indexed-name": "Bair T.B."}, {"@seq": "4", "ce:initials": "J.G.", "@_fa": "true", "ce:surname": "Moreland", "ce:indexed-name": "Moreland J.G."}, {"@seq": "5", "ce:initials": "M.D.", "@_fa": "true", "ce:surname": "Henry", "ce:indexed-name": "Henry M.D."}]}, "ref-sourcetitle": "Mol Biol Cell"}}, {"ref-fulltext": "Hafeez BB, Zhong W, Fischer JW, et al. 2013. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol Oncol 7: 428\u2013439.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model"}, "refd-itemidlist": {"itemid": {"$": "84878142242", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "428", "@last": "439"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.B.", "@_fa": "true", "ce:surname": "Hafeez", "ce:indexed-name": "Hafeez B.B."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Zhong", "ce:indexed-name": "Zhong W."}, {"@seq": "3", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Fischer", "ce:indexed-name": "Fischer J.W."}], "et-al": null}, "ref-sourcetitle": "Mol Oncol"}}, {"ref-fulltext": "Hiscox S, Jiang WG, Obermeier K, et al. 2006. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118: 290\u2013301.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation"}, "refd-itemidlist": {"itemid": {"$": "28844494352", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "118"}, "pagerange": {"@first": "290", "@last": "301"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Hiscox", "ce:indexed-name": "Hiscox S."}, {"@seq": "2", "ce:initials": "W.G.", "@_fa": "true", "ce:surname": "Jiang", "ce:indexed-name": "Jiang W.G."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Obermeier", "ce:indexed-name": "Obermeier K."}], "et-al": null}, "ref-sourcetitle": "Int J Cancer"}}, {"ref-fulltext": "List HJ, Reiter R, Singh B, Wellstein A, Riegel AT. 2001. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat 68: 21\u201328.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue"}, "refd-itemidlist": {"itemid": {"$": "0034814296", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "21", "@last": "28"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "List", "ce:indexed-name": "List H.J."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Reiter", "ce:indexed-name": "Reiter R."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Singh", "ce:indexed-name": "Singh B."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Wellstein", "ce:indexed-name": "Wellstein A."}, {"@seq": "5", "ce:initials": "A.T.", "@_fa": "true", "ce:surname": "Riegel", "ce:indexed-name": "Riegel A.T."}]}, "ref-sourcetitle": "Breast Cancer Res Treat"}}, {"ref-fulltext": "Loboda A, Nebozhyn M, Watters J, et al. 2011. EMT is the dominant program in human colon cancer. BMC Med Genomics 4: 9.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "EMT is the dominant program in human colon cancer"}, "refd-itemidlist": {"itemid": {"$": "78651529782", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "9"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Loboda", "ce:indexed-name": "Loboda A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nebozhyn", "ce:indexed-name": "Nebozhyn M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Watters", "ce:indexed-name": "Watters J."}], "et-al": null}, "ref-sourcetitle": "BMC Med Genomics"}}, {"ref-fulltext": "Lonard DM, Tsai SY, O'Malley BW. 2004. Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Mol Cell Biol 24: 14\u201324.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins"}, "refd-itemidlist": {"itemid": {"$": "0345732644", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "14", "@last": "24"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Lonard", "ce:indexed-name": "Lonard D.M."}, {"@seq": "2", "ce:initials": "S.Y.", "@_fa": "true", "ce:surname": "Tsai", "ce:indexed-name": "Tsai S.Y."}, {"@seq": "3", "ce:initials": "B.W.", "@_fa": "true", "ce:surname": "O'Malley", "ce:indexed-name": "O'Malley B.W."}]}, "ref-sourcetitle": "Mol Cell Biol"}}, {"ref-fulltext": "Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V. 2011. Endocrine therapy of breast cancer. Curr Med Chem 18: 513\u2013522.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Endocrine therapy of breast cancer"}, "refd-itemidlist": {"itemid": {"$": "79851471023", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "513", "@last": "522"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Lumachi", "ce:indexed-name": "Lumachi F."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Luisetto", "ce:indexed-name": "Luisetto G."}, {"@seq": "3", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Basso", "ce:indexed-name": "Basso S.M."}, {"@seq": "4", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Basso", "ce:indexed-name": "Basso U."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Brunello", "ce:indexed-name": "Brunello A."}, {"@seq": "6", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Camozzi", "ce:indexed-name": "Camozzi V."}]}, "ref-sourcetitle": "Curr Med Chem"}}, {"ref-fulltext": "Lydon JP, O'Malley BW. 2011. Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology 152: 19\u201325.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis"}, "refd-itemidlist": {"itemid": {"$": "78650842398", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "152"}, "pagerange": {"@first": "19", "@last": "25"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Lydon", "ce:indexed-name": "Lydon J.P."}, {"@seq": "2", "ce:initials": "B.W.", "@_fa": "true", "ce:surname": "O'Malley", "ce:indexed-name": "O'Malley B.W."}]}, "ref-sourcetitle": "Endocrinology"}}, {"ref-fulltext": "Magnusson C, Baron JA, Correia N, Bergstr\u00f6m R, Adami H-O, Persson I. 1999. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81: 339\u2013344.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy"}, "refd-itemidlist": {"itemid": {"$": "0032963863", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "81"}, "pagerange": {"@first": "339", "@last": "344"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Magnusson", "ce:indexed-name": "Magnusson C."}, {"@seq": "2", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Baron", "ce:indexed-name": "Baron J.A."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Correia", "ce:indexed-name": "Correia N."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Bergstr\u00f6m", "ce:indexed-name": "Bergstrom R."}, {"@seq": "5", "ce:initials": "H.-O.", "@_fa": "true", "ce:surname": "Adami", "ce:indexed-name": "Adami H.-O."}, {"@seq": "6", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Persson", "ce:indexed-name": "Persson I."}]}, "ref-sourcetitle": "Int J Cancer"}}, {"ref-fulltext": "Manu KA, Shanmugam MK, Rajendran P, et al. 2011. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4. Mol Cancer 10: 107.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4"}, "refd-itemidlist": {"itemid": {"$": "80052167167", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "107"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Manu", "ce:indexed-name": "Manu K.A."}, {"@seq": "2", "ce:initials": "M.K.", "@_fa": "true", "ce:surname": "Shanmugam", "ce:indexed-name": "Shanmugam M.K."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rajendran", "ce:indexed-name": "Rajendran P."}], "et-al": null}, "ref-sourcetitle": "Mol Cancer"}}, {"ref-fulltext": "Martin TA, Goyal A, Watkins G, Jiang WG. 2005. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12: 488\u2013496.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer"}, "refd-itemidlist": {"itemid": {"$": "21244437500", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "488", "@last": "496"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.A.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin T.A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Goyal", "ce:indexed-name": "Goyal A."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Watkins", "ce:indexed-name": "Watkins G."}, {"@seq": "4", "ce:initials": "W.G.", "@_fa": "true", "ce:surname": "Jiang", "ce:indexed-name": "Jiang W.G."}]}, "ref-sourcetitle": "Ann Surg Oncol"}}, {"ref-fulltext": "Musgrove EA, Sutherland RL. 2009. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9: 631\u2013643.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Biological determinants of endocrine resistance in breast cancer"}, "refd-itemidlist": {"itemid": {"$": "69249137029", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "631", "@last": "643"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Musgrove", "ce:indexed-name": "Musgrove E.A."}, {"@seq": "2", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Sutherland", "ce:indexed-name": "Sutherland R.L."}]}, "ref-sourcetitle": "Nat Rev Cancer"}}, {"ref-fulltext": "Osborne CK, Bardou V, Hopp TA, et al. 2003. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95: 353\u2013361.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer"}, "refd-itemidlist": {"itemid": {"$": "0037420192", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "95"}, "pagerange": {"@first": "353", "@last": "361"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.K.", "@_fa": "true", "ce:surname": "Osborne", "ce:indexed-name": "Osborne C.K."}, {"@seq": "2", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Bardou", "ce:indexed-name": "Bardou V."}, {"@seq": "3", "ce:initials": "T.A.", "@_fa": "true", "ce:surname": "Hopp", "ce:indexed-name": "Hopp T.A."}], "et-al": null}, "ref-sourcetitle": "J Natl Cancer Inst"}}, {"ref-fulltext": "Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. 2012. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 32: 1131\u20131158.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Perspectives on medicinal properties of plumbagin and its analogs"}, "refd-itemidlist": {"itemid": {"$": "84867407020", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "1131", "@last": "1158"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Padhye", "ce:indexed-name": "Padhye S."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Dandawate", "ce:indexed-name": "Dandawate P."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Yusufi", "ce:indexed-name": "Yusufi M."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ahmad", "ce:indexed-name": "Ahmad A."}, {"@seq": "5", "ce:initials": "F.H.", "@_fa": "true", "ce:surname": "Sarkar", "ce:indexed-name": "Sarkar F.H."}]}, "ref-sourcetitle": "Med Res Rev"}}, {"ref-fulltext": "Pelletier L, Rebouissou S, Vignjevic D, Bioulac-Sage P, Zucman-Rossi J. 2011. HNF1alpha inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines. BMC Cancer 11: 427.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "HNF1alpha inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines"}, "refd-itemidlist": {"itemid": {"$": "80053475842", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "427"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Pelletier", "ce:indexed-name": "Pelletier L."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Rebouissou", "ce:indexed-name": "Rebouissou S."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Vignjevic", "ce:indexed-name": "Vignjevic D."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Bioulac-Sage", "ce:indexed-name": "Bioulac-Sage P."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Zucman-Rossi", "ce:indexed-name": "Zucman-Rossi J."}]}, "ref-sourcetitle": "BMC Cancer"}}, {"ref-fulltext": "Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. 2006. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 281: 17023\u201317033.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents"}, "refd-itemidlist": {"itemid": {"$": "33745220306", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "281"}, "pagerange": {"@first": "17023", "@last": "17033"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.K.", "@_fa": "true", "ce:surname": "Sandur", "ce:indexed-name": "Sandur S.K."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ichikawa", "ce:indexed-name": "Ichikawa H."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Sethi", "ce:indexed-name": "Sethi G."}, {"@seq": "4", "ce:initials": "K.S.", "@_fa": "true", "ce:surname": "Ahn", "ce:indexed-name": "Ahn K.S."}, {"@seq": "5", "ce:initials": "B.B.", "@_fa": "true", "ce:surname": "Aggarwal", "ce:indexed-name": "Aggarwal B.B."}]}, "ref-sourcetitle": "J Biol Chem"}}, {"ref-fulltext": "Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin 65: 5\u201329.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Cancer statistics, 2015"}, "refd-itemidlist": {"itemid": {"$": "84920837701", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "65"}, "pagerange": {"@first": "5", "@last": "29"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Siegel", "ce:indexed-name": "Siegel R.L."}, {"@seq": "2", "ce:initials": "K.D.", "@_fa": "true", "ce:surname": "Miller", "ce:indexed-name": "Miller K.D."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Jemal", "ce:indexed-name": "Jemal A."}]}, "ref-sourcetitle": "CA Cancer J Clin"}}, {"ref-fulltext": "Sylvester PW. 2011. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol 716: 157\u2013168.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability"}, "refd-itemidlist": {"itemid": {"$": "79956204057", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "716"}, "pagerange": {"@first": "157", "@last": "168"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.W.", "@_fa": "true", "ce:surname": "Sylvester", "ce:indexed-name": "Sylvester P.W."}]}, "ref-sourcetitle": "Methods Mol Biol"}}, {"ref-fulltext": "Tian L, Yin D, Ren Y, Gong C, Chen A, Guo FJ. 2012. Plumbagin induces apoptosis via the p53 pathway and generation of reactive oxygen species in human osteosarcoma cells. Mol Med Rep 5: 126\u2013132.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Plumbagin induces apoptosis via the p53 pathway and generation of reactive oxygen species in human osteosarcoma cells"}, "refd-itemidlist": {"itemid": {"$": "84855241139", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "126", "@last": "132"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Tian", "ce:indexed-name": "Tian L."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Yin", "ce:indexed-name": "Yin D."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Ren", "ce:indexed-name": "Ren Y."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gong", "ce:indexed-name": "Gong C."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen A."}, {"@seq": "6", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Guo", "ce:indexed-name": "Guo F.J."}]}, "ref-sourcetitle": "Mol Med Rep"}}, {"ref-fulltext": "Weiner M, Skoog L, Fornander T, Nordenskj\u00f6ld B, Sgroi DC, St\u00e5l O. 2013. Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer. Ann Oncol 24: 1994\u20131999.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer"}, "refd-itemidlist": {"itemid": {"$": "84881234507", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "1994", "@last": "1999"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Weiner", "ce:indexed-name": "Weiner M."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Skoog", "ce:indexed-name": "Skoog L."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Fornander", "ce:indexed-name": "Fornander T."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Nordenskj\u00f6ld", "ce:indexed-name": "Nordenskjold B."}, {"@seq": "5", "ce:initials": "D.C.", "@_fa": "true", "ce:surname": "Sgroi", "ce:indexed-name": "Sgroi D.C."}, {"@seq": "6", "ce:initials": "O.", "@_fa": "true", "ce:surname": "St\u00e5l", "ce:indexed-name": "Stal O."}]}, "ref-sourcetitle": "Ann Oncol"}}, {"ref-fulltext": "Yan W, Wang TY, Fan QM, et al. 2014. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice. Acta Pharmacol Sin 35: 124\u2013134.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice"}, "refd-itemidlist": {"itemid": {"$": "84891818898", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "124", "@last": "134"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Yan", "ce:indexed-name": "Yan W."}, {"@seq": "2", "ce:initials": "T.Y.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang T.Y."}, {"@seq": "3", "ce:initials": "Q.M.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan Q.M."}], "et-al": null}, "ref-sourcetitle": "Acta Pharmacol Sin"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-84981718135", "dc:description": "Tamoxifen is widely used as the first line drug for estrogen receptor-positive subtype which is expressed in 70% of overall breast cancer patients. However, approximately 50% of these patients develop acquired resistance after 5 years of treatment, which is characterized by tumor recurrence and metastasis. The epithelial mesenchymal transition (EMT) is an important process in breast cancer invasion. Fundamentally, targeting the EMT represents a crucial therapeutic strategy for preventing or treating breast cancer metastasis. Plumbagin (PLB) is a natural naphthoquinone with significant anticancer effects against several types of tumor cells including breast cancer. In this study, we investigated the effect of PLB on human endocrine-resistant breast cancer cell growth, invasion and the possible mechanisms underlying such actions. PLB exhibited potent cytotoxic activity at a micromolar concentration against endocrine-resistant breast cancer cells. Interestingly, a fixed low concentration of PLB and tamoxifen combination resulted in an increase in growth inhibition in endocrine-resistant cells. In addition, PLB also significantly suppressed mesenchymal biomarker expressions that govern the EMT process, resulting in attenuated metastatic capabilities. In conclusion, PLB should be developed as a pharmacological agent for the use as a single treatment or in combination for endocrine-resistant breast cancer. Copyright \u00a9 2016 John Wiley & Sons, Ltd.", "pubmed-id": "27530731", "prism:coverDate": "2016-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84981718135", "dc:creator": {"author": [{"ce:given-name": "Nithidol", "preferred-name": {"ce:given-name": "Nithidol", "ce:initials": "N.", "ce:surname": "Sakunrangsit", "ce:indexed-name": "Sakunrangsit N."}, "@seq": "1", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sakunrangsit", "@auid": "57190619358", "author-url": "https://api.elsevier.com/content/author/author_id/57190619358", "ce:indexed-name": "Sakunrangsit N."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84981718135"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981718135&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84981718135&origin=inward"}], "source-id": "16573", "citedby-count": "31", "prism:volume": "30", "subtype": "ar", "dc:title": "Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation", "openaccess": "0", "prism:issn": "10991573 0951418X", "publishercopyright": "Copyright \u00a9 2016 John Wiley & Sons, Ltd.", "prism:issueIdentifier": "12", "subtypeDescription": "Article", "prism:publicationName": "Phytotherapy Research", "prism:pageRange": "1968-1977", "prism:endingPage": "1977", "openaccessFlag": "false", "prism:doi": "10.1002/ptr.5702", "prism:startingPage": "1968", "dc:identifier": "SCOPUS_ID:84981718135", "dc:publisher": "John Wiley and Sons LtdSouthern GateChichester, West SussexPO19 8SQ"}, "idxterms": {"mainterm": [{"$": "Anticoagulants", "@weight": "b", "@candidate": "n"}, {"$": "Breast Neoplasms", "@weight": "b", "@candidate": "n"}, {"$": "Cell Line, Tumor", "@weight": "b", "@candidate": "n"}, {"$": "Drug Resistance, Neoplasm", "@weight": "b", "@candidate": "n"}, {"$": "Epithelial-Mesenchymal Transition", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Naphthoquinones", "@weight": "b", "@candidate": "n"}, {"$": "Tamoxifen", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "cytotoxicity"}, {"@_fa": "true", "$": "EMT"}, {"@_fa": "true", "$": "endocrine-resistant breast cancer"}, {"@_fa": "true", "$": "metastasis"}, {"@_fa": "true", "$": "plumbagin"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}]}, "authors": {"author": [{"ce:given-name": "Nithidol", "preferred-name": {"ce:given-name": "Nithidol", "ce:initials": "N.", "ce:surname": "Sakunrangsit", "ce:indexed-name": "Sakunrangsit N."}, "@seq": "1", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sakunrangsit", "@auid": "57190619358", "author-url": "https://api.elsevier.com/content/author/author_id/57190619358", "ce:indexed-name": "Sakunrangsit N."}, {"ce:given-name": "Nuttiya", "preferred-name": {"ce:given-name": "Nuttiya", "ce:initials": "N.", "ce:surname": "Kalpongnukul", "ce:indexed-name": "Kalpongnukul N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Kalpongnukul", "@auid": "56784217400", "author-url": "https://api.elsevier.com/content/author/author_id/56784217400", "ce:indexed-name": "Kalpongnukul N."}, {"ce:given-name": "Trairak", "preferred-name": {"ce:given-name": "Trairak", "ce:initials": "T.", "ce:surname": "Pisitkun", "ce:indexed-name": "Pisitkun T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Pisitkun", "@auid": "6507728111", "author-url": "https://api.elsevier.com/content/author/author_id/6507728111", "ce:indexed-name": "Pisitkun T."}, {"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Ketchart", "@auid": "37029887800", "author-url": "https://api.elsevier.com/content/author/author_id/37029887800", "ce:indexed-name": "Ketchart W."}]}}}